Solventum Corp (SOLV)
Surgical & Medical Instruments & Apparatus · Healthcare · $13.3B
Intrinsic Value (Consensus)
$113.35
Current Price
$76.56
Margin of Safety
+48.1%
48.1% Below Intrinsic Value
Value: $113
Price: $77
Valuation Model Estimates
Current Price: $76.56
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$76.24
Earnings Power Value
$86.21
Relative Value (P/E)
$177.60
Dividend Discount Model
Not applicable
—
Consensus Value
$113.35
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
69
Profitability
25/25
Strength
9/25
Valuation
22/25
Growth
13/25
Financial Health Signals
Negative free cash flow — company is burning cash
Strong profitability — ROE of 31% (above 20% is excellent)
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $8.88
- EPS (Forward)
- $10.66
- Book Value
- $29.10
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 30.8%
- Debt/Equity
- 100%
- Revenue Growth
- 0.9%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance